Does PRAZAXA Cause Interstitial lung disease? 8 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Interstitial lung disease have been filed in association with PRAZAXA. This represents 5.0% of all adverse event reports for PRAZAXA.
8
Reports of Interstitial lung disease with PRAZAXA
5.0%
of all PRAZAXA reports
2
Deaths
6
Hospitalizations
How Dangerous Is Interstitial lung disease From PRAZAXA?
Of the 8 reports, 2 (25.0%) resulted in death, 6 (75.0%) required hospitalization, and 1 (12.5%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PRAZAXA. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does PRAZAXA Cause?
Cerebral infarction (20)
Embolic stroke (12)
Drug ineffective (10)
Cardiac failure (9)
Activated partial thromboplastin time prolonged (8)
Cardiac failure chronic (6)
Fall (6)
Death (5)
Renal impairment (5)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which PRAZAXA Alternatives Have Lower Interstitial lung disease Risk?
PRAZAXA vs PRAZEPAM
PRAZAXA vs PRAZIQUANTEL
PRAZAXA vs PRAZOSIN
PRAZAXA vs PREDNICARBATE
PRAZAXA vs PREDNISOLONE